Dr. Mark Kris, MD of Memorial Sloan Kettering discusses the Lung Cancer Mutation Consortium and the role of Next Generation Sequencing in NSCLC.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content